Analysen von Michael Leuchten
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | Merck Neutral | UBS AG | |
| 28.03.19 | Bayer buy | UBS AG | |
| 15.03.19 | Merck Neutral | UBS AG | |
| 07.03.19 | Merck buy | UBS AG | |
| 27.02.19 | Bayer buy | UBS AG | |
| 22.02.19 | Bayer buy | UBS AG | |
| 20.02.19 | Sartorius vz. Neutral | UBS AG | |
|
Werbung
|
|||
| 12.02.19 | Bayer buy | UBS AG | |
| 07.02.19 | GSK buy | UBS AG | |
| 30.01.19 | Novartis Neutral | UBS AG | |
| 29.01.19 | Sartorius vz. buy | UBS AG | |
| 18.01.19 | Novartis Neutral | UBS AG | |
| 02.01.19 | GSK buy | UBS AG | |
| 13.12.18 | Sartorius vz. buy | UBS AG | |
| 06.12.18 | Bayer buy | UBS AG | |
| 04.12.18 | GSK buy | UBS AG | |
| 30.11.18 | Novo Nordisk buy | UBS AG | |
| 26.11.18 | Novo Nordisk buy | UBS AG | |
| 21.11.18 | Novartis Neutral | UBS AG | |
| 13.11.18 | Bayer buy | UBS AG | |
| 05.11.18 | Novo Nordisk buy | UBS AG | |
| 01.11.18 | Novo Nordisk buy | UBS AG | |
| 01.11.18 | GSK buy | UBS AG | |
| 23.10.18 | Sartorius vz. Neutral | UBS AG | |
| 23.10.18 | Bayer buy | UBS AG | |
| 17.10.18 | Merck buy | UBS AG | |
| 11.10.18 | Bayer buy | UBS AG | |
| 10.10.18 | Novo Nordisk buy | UBS AG | |
| 05.10.18 | Novo Nordisk buy | UBS AG | |
| 27.09.18 | GSK buy | UBS AG | |
| 25.09.18 | Novartis Neutral | UBS AG | |
| 18.09.18 | Bayer buy | UBS AG | |
| 11.09.18 | Novartis Neutral | UBS AG | |
| 05.09.18 | Bayer buy | UBS AG | |
| 30.08.18 | Bayer buy | UBS AG | |
| 17.08.18 | Bayer buy | UBS AG | |
| 09.08.18 | Merck buy | UBS AG | |
| 08.08.18 | Novo Nordisk buy | UBS AG | |
| 03.08.18 | GSK buy | UBS AG | |
| 30.07.18 | GSK buy | UBS AG | |
| 26.07.18 | GSK buy | UBS AG | |
| 25.07.18 | Novo Nordisk buy | UBS AG | |
| 25.07.18 | GSK buy | UBS AG | |
| 23.07.18 | GSK buy | UBS AG | |
| 20.07.18 | Novartis Neutral | UBS AG | |
| 19.07.18 | Novartis Neutral | UBS AG | |
| 02.07.18 | Novartis Neutral | UBS AG | |
| 02.07.18 | GSK buy | UBS AG | |
| 26.06.18 | Bayer buy | UBS AG | |